Phase I study of defactinib combined with pembrolizumab and gemcitabine in advanced cancer.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Washington University in St. Louis
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2597553885
